These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 6300633)

  • 1. Pseudohypoparathyroidism: mutation affecting adenylate cyclase.
    Farfel Z; Bourne HR
    Miner Electrolyte Metab; 1982; 8(3-4):227-36. PubMed ID: 6300633
    [No Abstract]   [Full Text] [Related]  

  • 2. Pseudohypoparathyroidism: deficiency of hormone receptor-adenylate cyclase coupling protein as a cause of hereditary hormone resistance.
    Spiegel AM; Levine MA
    Prog Clin Biol Res; 1982; 97():327-40. PubMed ID: 6296880
    [No Abstract]   [Full Text] [Related]  

  • 3. [Pseudohypoparathyroidism: a generalized and multiple disorder in the adenyl cyclase system].
    Stögmann W
    Padiatr Padol; 1983; 18(3):243-6. PubMed ID: 6310469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibroblast defect in pseudohypoparathyroidism, type I: reduced activity of receptor-cyclase coupling protein.
    Bourne HR; Kaslow HR; Brickman AS; Farfel Z
    J Clin Endocrinol Metab; 1981 Sep; 53(3):636-40. PubMed ID: 6267099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pseudohypoparathyroidism: the molecular basis for hormone resistance--a retrospective.
    Spiegel AM; Levine MA; Marx SJ; Aurbach GD
    N Engl J Med; 1982 Sep; 307(11):679-81. PubMed ID: 6287258
    [No Abstract]   [Full Text] [Related]  

  • 6. Pseudohypoparathyroidism: an inherited disorder of adenylate cyclase.
    Bourne HR; Farfel Z; Brickman AS
    Adv Cyclic Nucleotide Res; 1981; 14():43-9. PubMed ID: 6269394
    [No Abstract]   [Full Text] [Related]  

  • 7. [Physiopathology of pseudohypoparathyroidism].
    Ogata E
    Nihon Naibunpi Gakkai Zasshi; 1991; 67 Suppl 1():132-43. PubMed ID: 1646133
    [No Abstract]   [Full Text] [Related]  

  • 8. Mutations of adenylate cyclase in yeast, mouse, and man.
    Bourne HR; Casperson GF; Van Dop C; Abood ME; Beiderman BB; Steinberg F; Walker N
    Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 17():199-205. PubMed ID: 6328916
    [No Abstract]   [Full Text] [Related]  

  • 9. Rapid GDP release from Gs alpha in patients with gain and loss of endocrine function.
    Iiri T; Herzmark P; Nakamoto JM; van Dop C; Bourne HR
    Nature; 1994 Sep; 371(6493):164-8. PubMed ID: 8072545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteodystrophy: biochemical defect in pseudohypoparathyroidism.
    Aurbach GD
    Birth Defects Orig Artic Ser; 1970 Sep; 6(3):24-5. PubMed ID: 4331338
    [No Abstract]   [Full Text] [Related]  

  • 11. [Pseudohypoparathyroidism. Disease of the second messenger].
    Stögmann W
    Fortschr Med; 1976 Oct; 94(29):1638-40. PubMed ID: 186374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hormonal control of the calcium permeability of cell membranes].
    Orlov RS; Barabanova VV
    Usp Fiziol Nauk; 1978; 9(2):76-102. PubMed ID: 209635
    [No Abstract]   [Full Text] [Related]  

  • 13. Resistance to multiple hormones in patients with pseudohypoparathyroidism. Association with deficient activity of guanine nucleotide regulatory protein.
    Levine MA; Downs RW; Moses AM; Breslau NA; Marx SJ; Lasker RD; Rizzoli RE; Aurbach GD; Spiegel AM
    Am J Med; 1983 Apr; 74(4):545-56. PubMed ID: 6301273
    [No Abstract]   [Full Text] [Related]  

  • 14. Pseudohypoparathyroidism.
    Johns Hopkins Med J; 1982 Sep; 151(3):137-46. PubMed ID: 6287085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deficiency of hormone receptor-adenylate cyclase coupling protein: basis for hormone resistance in pseudohypoparathyroidism.
    Spiegel AM; Levine MA; Aurbach GD; Downs RW; Marx SJ; Lasker RD; Moses AM; Breslau NA
    Am J Physiol; 1982 Jul; 243(1):E37-42. PubMed ID: 6283911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defective stimulation of adipocyte adenylate cyclase, blunted lipolysis, and obesity in pseudohypoparathyroidism 1a.
    Kaartinen JM; Käär ML; Ohisalo JJ
    Pediatr Res; 1994 May; 35(5):594-7. PubMed ID: 8065843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pseudohypoparathyroidism.
    Van Dop C; Bourne HR
    Annu Rev Med; 1983; 34():259-66. PubMed ID: 6344759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pseudohypoparathyroidism].
    Usa T
    Nihon Rinsho; 1972 Nov; 30(11):2312-6. PubMed ID: 4346766
    [No Abstract]   [Full Text] [Related]  

  • 19. Hormone resistance caused by mutations in G proteins and G protein-coupled receptors.
    Spiegel AM
    J Pediatr Endocrinol Metab; 1999 Apr; 12 Suppl 1():303-9. PubMed ID: 10698594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pseudohypoparathyroidism: clinical and molecular aspects.
    Van Dop C
    Semin Nephrol; 1989 Jun; 9(2):168-78. PubMed ID: 2505351
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.